Grifols SA (GRFS)
7.85
-0.01
(-0.13%)
USD |
NASDAQ |
Jan 07, 16:00
7.87
+0.02
(+0.25%)
After-Hours: 20:00
Grifols Profit Margin (Quarterly): 2.88% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Trinity Biotech PLC | -31.41% |
| Akari Therapeutics PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| Cellectis SA | -142.3% |
| Evaxion Biotech AS | -64.14% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.43% |
| Return on Assets | 0.93% |
| Return on Invested Capital | 1.23% |
| Gross Profit Margin (Quarterly) | 40.53% |
| Operating Margin (Quarterly) | 17.82% |
| Return on Net Operating Assets | 1.06% |